Montelukast as an Alternative to Low-Dose Inhaled Corticosteroids in the Management of Mild Asthma (The SIMPLE Trial): An Open-Label Effectiveness Trial

R Andrew McIvor; Alan Kaplan; Caroline Koch; John S Sampalis

doi:10.1155/2009/429482

Canadian Respiratory Journal (Jan 2009)

Montelukast as an Alternative to Low-Dose Inhaled Corticosteroids in the Management of Mild Asthma (The SIMPLE Trial): An Open-Label Effectiveness Trial

R Andrew McIvor,
Alan Kaplan,
Caroline Koch,
John S Sampalis

Affiliations

R Andrew McIvor: Firestone Institute of Respiratory Health, McMaster University, Hamilton, Canada
Alan Kaplan: York Central Hospital, Richmond Hill, Ontario, Canada
Caroline Koch: Merck Frosst Canada Limited, Kirkland, Canada
John S Sampalis: JSS Medical Research Inc., Montreal, Canada

DOI: https://doi.org/10.1155/2009/429482
Journal volume & issue: Vol. 16, no. Suppl A
pp. 11A – 16A

Abstract

Read online

OBJECTIVE: To evaluate the effectiveness of montelukast as monotherapy for patients with mild asthma who remain uncontrolled or unsatisfied while on inhaled corticosteroid (ICS) monotherapy.

Published in Canadian Respiratory Journal

ISSN: 1198-2241 (Print); 1916-7245 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the respiratory system
Website: https://onlinelibrary.wiley.com/journal/7503

About the journal